Docket Number:12A-1050113
Inventor:Cathy Fann, Tien-Chun Chang, Pei-Lung Chen, Wei-Shiung Yang, Shyang-Rong Shih
IP Status:Pending
Abstract:
The present invention relates to a method for assessing the risk of adverse drug reaction by detecting the risk allele(s) of antithyroid drug-induced agranulocytosis of a patient. The present invention further relates to a device for assessing said risk of adverse reaction.
Fields of Application:
For all individuals who need to start to take anti-thyroid drugs to treat thyroid hyperfunction, it may be beneficial to receive the test to predict the risk of the severe drug adverse effect, agranulocytosis. Agranulocytosis, which means a drop of neutrophil counts down to zero, can be fatal if the salvage treatment is not effective, or not timely enough. According to epidemiology data, there might be ~0.5%-1% individuals with thyroid hyperfunction sometime in their life, and therefore need to take anti-thyroid drugs.
Advantages when compared to the existing technologies:
There were no previous existing technologies that can make the risk prediction.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
